A prospective study analyzing response to COVID19 vaccines in patients with inflammatory bowel disease
Latest Information Update: 09 Sep 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 09 Sep 2022 New trial record
- 06 Sep 2022 Results published in the Journal of Gastroenterology and Hepatology